Cargando…
Metabolic Syndrome-Related Hyperuricemia is Associated with a Poorer Prognosis in Patients with Colorectal Cancer: A Multicenter Retrospective Study
PURPOSE: Hyperuricemia and metabolic syndrome (MetS) have been shown to correlate with prognosis in patients with malignant tumors. The present study evaluated the relationship between preoperative hyperuricemia and MetS in colorectal cancer (CRC) patients and analyzed the effect of this combination...
Autores principales: | Feng, Qian, Tang, Liang-Jie, Luo, Ding-Hai, Wang, Ying, Wu, Nan, Chen, Hao, Chen, Meng-Xia, Jiang, Lei, Jin, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633709/ https://www.ncbi.nlm.nih.gov/pubmed/34866939 http://dx.doi.org/10.2147/CMAR.S338783 |
Ejemplares similares
-
Hyperuricemia prevalence and its association with metabolic disorders: a multicenter retrospective real-world study in China
por: Pang, Shuguang, et al.
Publicado: (2021) -
Vitamin D deficiency linked to abnormal bone and lipid metabolism predicts high-risk multiple myeloma with poorer prognosis
por: Bao, Li, et al.
Publicado: (2023) -
Subphrenic Lymph Node Metastasis Predicts Poorer Prognosis for Nasopharyngeal Carcinoma Patients With Metachronous Metastasis
por: Zhang, Xue-Fang, et al.
Publicado: (2021) -
Pseudohypoadrenalism, a subclinical cortisol metabolism disorder in hyperuricemia
por: Bao, Ruixia, et al.
Publicado: (2023) -
Do ethnic chinese older adults with epithelial ovarian cancer survive a poorer prognosis?
por: Huang, Wu, et al.
Publicado: (2023)